← FDA Drug Approvals (Drugs@FDA)

TEKAMLO

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2010-08-26

Drug application

FDA Application #

NDA022545

Application type

New Drug Application

Brand name

TEKAMLO

Generic name

Aliskiren Hemifumarate

Active ingredients

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

2010-08-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown